These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 19501927

  • 1. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

  • 2. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W, Liu X, Peng X, Xue R, Ji L, Shen X, Chen S, Gu J, Zhang S.
    Biochem Biophys Res Commun; 2014 May 23; 448(1):50-5. PubMed ID: 24747563
    [Abstract] [Full Text] [Related]

  • 3. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct 23; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 4. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W, Zhu B, Peng X, Zhou M, Jia D, Gu J.
    Biochem Biophys Res Commun; 2014 Jan 03; 443(1):68-73. PubMed ID: 24269813
    [Abstract] [Full Text] [Related]

  • 5. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M.
    Gut; 2007 Apr 03; 56(4):565-74. PubMed ID: 16950832
    [Abstract] [Full Text] [Related]

  • 6. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
    Meng Q, Duan XP, Wang CY, Liu ZH, Sun PY, Huo XK, Sun HJ, Peng JY, Liu KX.
    Acta Pharmacol Sin; 2017 Jan 03; 38(1):69-79. PubMed ID: 27773935
    [Abstract] [Full Text] [Related]

  • 7. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun H, Sun P, Yang X, Huo X, Peng J, Liu K.
    Phytomedicine; 2017 Feb 15; 25():83-92. PubMed ID: 28190475
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul 15; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 9. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P.
    J Gastroenterol Hepatol; 2006 Jan 15; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [Abstract] [Full Text] [Related]

  • 10. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep 15; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 11. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.
    Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902
    [Abstract] [Full Text] [Related]

  • 12. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ, Mahaney PE, Borges-Marcucci L, Lai K, Wang S, Krueger JA, Gardell SJ, Huard C, Martinez R, Vlasuk GP, Harnish DC.
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar 30; 296(3):G543-52. PubMed ID: 19136377
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 30; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 14. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y.
    J Hepatol; 2004 Dec 30; 41(6):926-34. PubMed ID: 15582125
    [Abstract] [Full Text] [Related]

  • 15. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA.
    Gastroenterology; 2007 Aug 30; 133(2):608-18. PubMed ID: 17681180
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A, Leclercq IA, Williams J, Farrell GC.
    J Hepatol; 2007 Feb 30; 46(2):304-13. PubMed ID: 17157947
    [Abstract] [Full Text] [Related]

  • 17. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T.
    Int J Clin Exp Pathol; 2013 Feb 30; 6(12):2683-96. PubMed ID: 24294355
    [Abstract] [Full Text] [Related]

  • 18. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb 30; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 19. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS, Lammert F, Igolnikov A, Green RM.
    Liver Int; 2006 Oct 30; 26(8):1000-5. PubMed ID: 16953841
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C, Tacke F.
    Gut; 2012 Mar 30; 61(3):416-26. PubMed ID: 21813474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.